SCHEMBL7564868

SCHEMBL7564868

CCCCn1nc(-c2c(F)cccc2Cl)nc1-c1sc(Cl)c(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 1/20 0.41
HSF1 Q00613 3/20 0.34
ESR1 P03372 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.32
PDE2A O00408 1/20 0.31
PDE10A Q9Y233 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 1/20 0.31
CRHR1 P34998 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
AKR1B1 P15121 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202844 0.83 PDE2A (0.35) NR1H3TRPM8PDE2APDE10AALDH1A1
SCHEMBL7471708 0.75 NR1H2 (0.38) NR1H3TRPM8MAPTCRHR1SMN1; SMN2
SCHEMBL7526323 0.73 PDE2A (0.34) NR1H3TRPM8PDE2APDE10ASMN1; SMN2
SCHEMBL7532307 0.72 PDE2A (0.33) NR1H3TRPM8PDE2APDE10AALDH1A1
SCHEMBL5726642 0.70 PDE2A (0.33) NR1H3TRPM8PDE2APDE10AMAPT
SCHEMBL9577157 0.69 HSD11B1 (0.46) NR1H3PDE2APDE10ACRHR1KMT2A
SCHEMBL7522944 0.68 KDM4E (0.32) PDE2APDE10AALDH1A1SMN1; SMN2LMNA
SCHEMBL7527087 0.68 PDE2A (0.35) NR1H3PDE2APDE10AALDH1A1MAPT
SCHEMBL6209661 0.68 PDE2A (0.37) NR1H3PDE2APDE10AALDH1A1MAPT
SCHEMBL9026017 0.67 HSD11B1 (0.49) NR1H3ALDH1A1MAPTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417187-B2 PALLADIUM CATALYZED ARYLATION, ALKYLATION, DEIODINATION OR DEBROMINATION DOW AGROSCIENCES LLC 2002-07-09 US disclosed
US-20020019370-A1 Palladium catalyzed arylation, alkylation, deiodination or debromination DOW AGROSCIENCES LLC 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019370-A1 Palladium catalyzed arylation, alkylation, deiodination or debromination DDT, TYR, DDC NR1H3 3235/4885HSF1 4624/4885ESR1 4004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.